Our lab investigates the immune response during cancer, to reveal the mechanisms limiting or contributing to an effective anti-tumor response in general, and in reaction to antibody-based immunotherapies. We employ advanced experimental systems to improve current treatment outcome, and to develop novel translational strategies as next-generation cancer immunotherapies.